Lassa Virus

DNA Vaccines Studied for Emerging Arenaviruses

Published in Vaccine Weekly, March 8th, 2000

Researchers from the United States are actively exploring potential DNA vaccines for prevention of Lassa virus.

"Lassa virus is a rodent born arenavirus endemic to West Africa which causes Lassa fever in man resulting in 3,000-5,000 deaths annually," reported M.J. Buchmeier and colleagues from the Scripps Research Institute and Epimmune Corporation, California, and the U.S. Centers for Disease Control, Georgia. "Early diagnosis of Lassa fever is difficult and effective treatment is not available making development of a vaccine a rational strategy to control this disease."

Buchmeier et al. presented data from their research at the meeting Molecular...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-03-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry